FDA Guidance on Cardiovascular Risk of Antidiabetic Therapies: One Decade Later

Diabetes, Obesity and Metabolism - United Kingdom
doi 10.1111/dom.13669
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Safety of Antidiabetic Therapies on Bone

2016English

Bayesian Meta-Experimental Design: Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes

Biometrics
StatisticsGeneticsProbabilityMolecular BiologyBiochemistryApplied MathematicsMicrobiology ImmunologyBiological SciencesMedicineAgricultural
2011English

Cardiovascular Risk Factor Burden in U.S. People With Incident Type 2 Diabetes Receiving Antidiabetic and Cardioprotective Therapies

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2019English

FDA Issues Draft Guidance on MRD Testing

Cancer Discovery
Oncology
2018English

Impact of Having One Cardiovascular Risk Factor on Other Cardiovascular Risk Factor Levels in Adolescents

Journal of Atherosclerosis and Thrombosis
BiochemistryInternal MedicineCardiovascular MedicineCardiology
2010English

The Token Economy: A Decade Later.

Journal of Applied Behavior Analysis
Applied PsychologyPhilosophySociologyPolitical Science
1982English

Ocular Toxoplasmosis and Host's Immunogenetic Risk Factors: One Decade of Investigations

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2019English

The Health Belief Model: A Decade Later

Health Education Quarterly
1984English

Repurposing FDA-approved Drugs for Anti-Aging Therapies

Biogerontology
AgingGerontologyGeriatrics
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy